Experimental Treatment for GLUT1 Deficiency Syndrome Falters in Clinical Trial
According to a story from Biospace, the biopharmaceutical company Ultragenyx Pharmaceutical Inc. recently reported that its experimental product UX007 failed to achieve its primary endpoint in a recent clinical trial.…